| Characteristics and Outcomes of Patients With Relapsed/Refractory Multiple Myeloma After Exposure to Lenalidomide in First Line of Therapy: A Single Center Database Review in … E Kastritis, I Ntanasis-Stathopoulos, F Theodorakakou, M Migkou, ... Clinical Lymphoma Myeloma and Leukemia 24 (7), 468-477, 2024 | | 2024 |
| Evaluation of a novel method to guide belantamab mafodotin dosing in multiple myeloma based on a patient-reported questionnaire. E Terpos, M Gavriatopoulou, I Ntanasis-Stathopoulos, P Malandrakis, ... Journal of Clinical Oncology 42 (16_suppl), 7530-7530, 2024 | | 2024 |
| Characteristics of Orthodontic Treatment in Cancer Survivors: A Systematic Review N Karvelas, I Ntanasis-Stathopoulos, MA Makrygiannakis, ... Journal of Clinical Medicine 13 (10), 2858, 2024 | | 2024 |
| Early microvascular coronary endothelial dysfunction precedes pembrolizumab-induced cardiotoxicity. Preventive role of high dose of atorvastatin P Efentakis, A Choustoulaki, G Kwiatkowski, A Varela, IV Kostopoulos, ... Basic Research in Cardiology, 1-24, 2024 | 1 | 2024 |
| Prognosis of COVID-19 severity using DERGA, a novel machine learning algorithm PG Asteris, AH Gandomi, DJ Armaghani, S Kokoris, AT Papandreadi, ... European Journal of Internal Medicine, 2024 | 2 | 2024 |
| Retinopathy in a Patient With IgM MGUS: Causal Association or an Epiphenomenon? I Ntanasis-Stathopoulos, E Kastritis, J Tzartos, E Terpos, MA Dimopoulos, ... In Vivo 38 (2), 954-957, 2024 | | 2024 |
| Belantamab mafodotin, lenalidomide, and dexamethasone in transplant-ineligible patients with newly diagnosed multiple myeloma: Analysis of belantamab mafodotin-associated … M Gavriatopoulou, I Ntanasis-Stathopoulos, P Malandrakis, D Fotiou, ... American journal of hematology 99 (3), 502-504, 2024 | | 2024 |
| Small RNA‐seq and clinical evaluation of tRNA‐derived fragments in multiple myeloma: Loss of mitochondrial i‐tRFHisGTG results in patients' poor treatment … K Soureas, MA Papadimitriou, P Malandrakis, AM Papanota, ... British Journal of Haematology, 2024 | | 2024 |
| Low circulating tumor cell levels correlate with favorable outcomes and distinct biological features in multiple myeloma IV Kostopoulos, I Ntanasis‐Stathopoulos, P Rousakis, P Malandrakis, ... American Journal of Hematology, 2024 | | 2024 |
| Simultaneous resections for colorectal cancer with synchronous liver metastases: Current state-of-the-art N Machairas, M Di Martino, F Primavesi, P Underwood, M de Santibanes, ... Journal of Gastrointestinal Surgery, 2024 | | 2024 |
| Thrombotic and bleeding complications in patients with AL amyloidosis D Fotiou, F Theodorakakou, S Spiliopoulou, M Gavriatopoulou, M Migkou, ... British Journal of Haematology, 2024 | | 2024 |
| Efficacy and immune modulation associated with the addition of IMiDs to Daratumumab backbone in multiple myeloma patients refractory to both drug classes: resetting synergistic … IV Kostopoulos, D Fotiou, M Gavriatopoulou, P Rousakis, ... Blood Cancer Journal 14 (1), 26, 2024 | | 2024 |
| A 74-Year-Old Man With Waldenström Macroglobulinemia and Progressive Dyspnea V Tzilas, AG Nicholson, M Gavriatopoulou, I Ntanasis-Stathopoulos, ... Chest 165 (2), e39-e43, 2024 | | 2024 |
| Efficacy and safety of daratumumab with ixazomib and dexamethasone in lenalidomide‐exposed patients after one prior line of therapy: Final results of the phase 2 study DARIA E Terpos, I Ntanasis‐Stathopoulos, M Gavriatopoulou, E Katodritou, ... American Journal of Hematology, 2024 | 1 | 2024 |
| High-Oxygen-Affinity Hemoglobins—Case Series and Review of the Literature V Komninaka, P Flevari, EE Ntelaki, E Yfanti, T Androutsakos, ... Journal of Clinical Medicine 13 (2), 458, 2024 | | 2024 |
| ciRS‐7 circular RNA overexpression in plasma cells is a promising molecular biomarker of unfavorable prognosis in multiple myeloma M Papatsirou, CK Kontos, I Ntanasis‐Stathopoulos, P Malandrakis, ... eJHaem, 2024 | | 2024 |
| Exploring the molecular biomarker utility of circCCT3 in multiple myeloma: A favorable prognostic indicator, particularly for R‐ISS II patients M Papatsirou, CK Kontos, I Ntanasis‐Stathopoulos, P Malandrakis, ... HemaSphere 8 (1), e34, 2024 | 1 | 2024 |
| Long-term Survival in a Patient With Transformation of Waldenström’s Macroglobulinemia into DLBCL E Solia, I Ntanasis-Stathopoulos, E Kastritis, E Terpos, MA Dimopoulos, ... Cancer Diagnosis & Prognosis 4 (1), 77, 2024 | | 2024 |
| The Role of t (11; 14) in Tailoring Treatment Decisions in Multiple Myeloma M Kleber, I Ntanasis-Stathopoulos, E Terpos Cancers 15 (24), 5829, 2023 | 1 | 2023 |
| Fully Automated Detection and Segmentation Pipeline for the Bone Marrow of the Lytic Bone of Multiple Myeloma Patients E Koutoulakis, E Trivizakis, V Koutoulidis, LA Moulopoulos, E Terpos, ... 2023 IEEE EMBS Special Topic Conference on Data Science and Engineering in …, 2023 | | 2023 |
Meletios Athanasios DimopoulosNational and Kapodistrian University of Athens, School of Medicine在 med.uoa.gr 的电子邮件经过验证
